Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.8M Sell
29,582
-250
-0.8% -$29.3K 2.76% 10
2026
Q1
$3.14M Hold
29,832
2.35% 11
2025
Q4
$3.14M Hold
29,832
2.35% 11
2025
Q3
$2.5M Sell
29,832
-2,331,669
-99% -$192M 1.83% 16
2025
Q2
$2.36B Buy
2,361,501
+2,331,519
+7,776% +$185M 1.84% 18
2025
Q1
$2.69M Hold
29,982
2.11% 13
2024
Q4
$2.98M Hold
29,982
2.29% 12
2024
Q3
$3.4M Sell
29,982
-250
-0.8% -$29.7K 2.51% 10
2024
Q2
$3.74M Hold
30,232
2.89% 8
2024
Q1
$3.99M Sell
30,232
-800
-3% -$98.6K 3.06% 7
2023
Q4
$3.38M Buy
+31,032
New +$3.22M 2.65% 8

Other funds holding MRK

Broadwater Capital's MRK Position: Q2 2026 in Review

Broadwater Capital reduced its Merck (MRK) stake by 0.84% in Q2 2026, selling an estimated $29.3K and leaving 29,582 shares worth $3.8M. The position accounts for 2.76% of the portfolio, ranked #10.

Broadwater Capital first reported a position in MRK in Q4 2023 and has held it in 11 quarters since. The position peaked at $2.36B in Q2 2025. 2,223 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Broadwater Capital held 29,582 shares of Merck worth $3.8M as of Q2 2026.
  • Broadwater Capital sold 250 Merck shares in Q2 2026, an estimated $29.3K.
  • Merck made up 2.76% of Broadwater Capital's portfolio in Q2 2026, its #10 holding.
  • Broadwater Capital first reported a position in Merck in Q4 2023 and has held it in 11 quarters since.
  • Broadwater Capital's Merck position peaked at $2.36B in Q2 2025.
  • 2,223 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Broadwater Capital's 13F filing for Q2 2026, filed 24 Jul 2026.